AVE 33.3% 0.2¢ avecho biotechnology limited

boost for global diclofenac gel market, page-9

  1. 642 Posts.
    lightbulb Created with Sketch. 9
    Not sure if this info has been raised yet, but diclofenac gel is being widely prescribed for sunspots by GPs and dermatologists alike. It is sold as Solaraze, but as far as I can see this is just a very expensive form of Voltaren emulgel. Reckon that TPM might just shorten the treatment period significantly and give POH a different foot into the same market.

    "Diclofenac gel (Solaraze™). Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that interferes with the development of sun spots. The gel is usually applied to the skin twice daily for 3 months. Most people develop few side effects, apart from some scaling and flaking. While this form of therapy has the advantage of minimal ‘down time’, the long treatment period can be a problem, and longer term cure rates are not yet known."


    http://www.innersydneydermatology.com.au/templates/isd/page/page_html_standard.php?secID=72
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.